Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

TGTX

TG Therapeutics Inc

May 29 • 04:00PM ET

37.94

-0.88 -2.27 %

Healthcare • Biotechnology • USA • Mid • NASD

Peers: INCY BMRN ACAD AXSM MDGL KRYS PTGX RYTM VKTX NBIX

| Held by: IJR VTI IWM XBI VB VBK VXF SPSM IJT IWO

Scroll to Statements

Index	RUT	P/E	13.22	EPS (ttm)	2.87	Insider Own	7.23%	Shs Outstand	153.09M	Perf Week	-3.31%
Market Cap	5.81B	Forward P/E	14.89	EPS next Y	2.55	Insider Trans	0.00%	Shs Float	142.01M	Perf Month	12.98%
Enterprise Value	6.05B	PEG	4.67	EPS next Q	0.33	Inst Own	69.15%	Short Float	19.79%	Perf Quarter	26.09%
Income	461.90M	P/S	8.29	EPS this Y	-53.61%	Inst Trans	0.84%	Short Ratio	13.73	Perf Half Y	15.04%
Sales	700.35M	P/B	9.96	EPS next Y	98.35%	ROA	42.27%	Short Interest	28.11M	Perf YTD	27.27%
Book/sh	3.81	P/C	11.29	EPS next 5Y	3.19%	ROE	112.60%	52W High	44.65 -15.03%	Perf Year	6.24%
Cash/sh	3.36	P/FCF	-	EPS past 3/5Y	- -	ROIC	34.60%	52W Low	25.28 50.08%	Perf 3Y	39.49%
Dividend Est.	-	EV/EBITDA	40.03	Sales past 3/5Y	504.86% 426.73%	Gross Margin	83.05%	Volatility	3.16% 4.40%	Perf 5Y	8.80%
Dividend TTM	-	EV/Sales	8.63	EPS Y/Y TTM	1079.73%	Oper. Margin	21.35%	ATR (14)	1.50	Perf 10Y	390.81%
Dividend Ex-Date	-	Quick Ratio	5.12	Sales Y/Y TTM	81.26%	Profit Margin	65.95%	RSI (14)	47.73	Recom	1.62
Dividend Gr. 3/5Y	- -	Current Ratio	5.81	EPS Q/Q	297.43%	SMA20	-4.51%	Beta	1.69	Target Price	48.00
Payout	0.00%	Debt/Eq	1.29	Sales Q/Q	69.56%	SMA50	4.94%	Rel Volume	0.60	Prev Close	38.82
Employees	399	LT Debt/Eq	1.29	Earnings	May 06 BMO	SMA200	16.74%	Avg Volume	2.05M	Price	37.94
IPO	Dec 14, 1995	Option/Short	Yes / Yes	EPS/Sales Surpr.	-56.44% 2.29%	Trades		Volume	1,223,121	Change	-2.27%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)